News & Updates

Show Multimedia Only

FUTURE-III trial reinforces potential of thinner-strut BRS for CAD

13 Oct 2025 by

In the FUTURE-III trial, the Firesorb bioresorbable scaffold (BRS) – a thinner-strut (100/125 µm) poly-L-lactic acid-based sirolimus-eluting BRS – exhibits promising 1-year efficacy and safety profiles in terms of target lesion failure (TLF).

FUTURE-III trial reinforces potential of thinner-strut BRS for CAD

13 Oct 2025

Physical disability a risk factor for hypertension

12 Oct 2025 by

Individuals with physical disability are predisposed to hypertension, new research suggests.

Physical disability a risk factor for hypertension

12 Oct 2025

Ultraprocessed foods reduce longevity among Asians

11 Oct 2025 by

Consuming ultraprocessed foods in large quantities can shorten the life expectancy of Asians, being associated with elevated risks of mortality from all causes, cardiovascular diseases, and respiratory diseases, as shown in a study from Singapore.

Ultraprocessed foods reduce longevity among Asians

11 Oct 2025

Aficamten outperforms metoprolol in obstructive HCM

11 Oct 2025 by

Two phase III trials presented at ESC 2025 have provided new insights into the role of myosin inhibitors in hypertrophic cardiomyopathy (HCM), with one trial demonstrating superiority over standard care in obstructive HCM and another failing to meet its primary endpoints in nonobstructive HCM.

Aficamten outperforms metoprolol in obstructive HCM

11 Oct 2025

Magnesium confers BP-lowering benefits in people with hypertension, hypomagnesemia

11 Oct 2025

Magnesium supplementation appears to substantially reduce blood pressure (BP) levels in individuals with hypertension and hypomagnesemia, especially those on antihypertensive medication, according to a systematic review and meta-analysis.

Magnesium confers BP-lowering benefits in people with hypertension, hypomagnesemia

11 Oct 2025

[Infographics] Two patients with dyslipidaemia treated with oral bempedoic acid + ezetimibe FDC

10 Oct 2025 by

Dr Walter Wai-Chee Chan's (Specialist in Cardiology in Hong Kong) cases: one patient with statin-induced autoimmune myositis, and another patient with uncontrolled LDL-C despite maximally tolerated statin + ezetimibe. Find out how these patients responded to and tolerated oral bempedoic acid + ezetimibe fixed-dose combination (FDC) treatment.

[Infographics] Two patients with dyslipidaemia treated with oral bempedoic acid + ezetimibe FDC

10 Oct 2025

Does anticoagulant use improve survival in PAH?

09 Oct 2025

The use of anticoagulant therapy offers no survival benefit in patients with pulmonary arterial hypertension (PAH), a recent study has shown.

Does anticoagulant use improve survival in PAH?

09 Oct 2025

Elevated serum uric acid tied to high-risk coronary artery plaques

09 Oct 2025

Individuals with increased serum uric acid have a higher likelihood of showing high-risk coronary artery plaques on coronary CT angiography (CCTA), as reported in a retrospective study.

Elevated serum uric acid tied to high-risk coronary artery plaques

09 Oct 2025

PPIs unlikely linked to increased stroke risk in patients taking antithrombotics

09 Oct 2025 by

Researchers at the University of Hong Kong (HKU) have found that the risk of ischaemic stroke is not increased in patients on proton-pump inhibitor (PPI) monotherapy, but is increased in those coprescribed with antithrombotic drugs, possibly due to their underlying higher risk profiles.

PPIs unlikely linked to increased stroke risk in patients taking antithrombotics

09 Oct 2025

Engaging in physical activity may prevent MACE, death in people with T2D

08 Oct 2025 by

An inverse association exists between self-reported physical activity (PA) and the risk of major adverse cardiac events (MACE) and all-cause mortality among individuals with type 2 diabetes (T2D) and no previous cardiovascular disease (CVD), suggests a study presented at EASD 2025.

Engaging in physical activity may prevent MACE, death in people with T2D

08 Oct 2025

News & Updates

Showing Cardiology articles

Showing

Specialty:

FUTURE-III trial reinforces potential of thinner-strut BRS for CAD

FUTURE-III trial reinforces potential of thinner-strut BRS for CAD

Physical disability a risk factor for hypertension

Physical disability a risk factor for hypertension

Ultraprocessed foods reduce longevity among Asians

Ultraprocessed foods reduce longevity among Asians

Aficamten outperforms metoprolol in obstructive HCM

Aficamten outperforms metoprolol in obstructive HCM

Magnesium confers BP-lowering benefits in people with hypertension, hypomagnesemia

Magnesium confers BP-lowering benefits in people with hypertension, hypomagnesemia

[Infographics] Two patients with dyslipidaemia treated with oral bempedoic acid + ezetimibe FDC

[Infographics] Two patients with dyslipidaemia treated with oral bempedoic acid + ezetimibe FDC

Does anticoagulant use improve survival in PAH?

Does anticoagulant use improve survival in PAH?

Elevated serum uric acid tied to high-risk coronary artery plaques

Elevated serum uric acid tied to high-risk coronary artery plaques

PPIs unlikely linked to increased stroke risk in patients taking antithrombotics

PPIs unlikely linked to increased stroke risk in patients taking antithrombotics

Engaging in physical activity may prevent MACE, death in people with T2D

Engaging in physical activity may prevent MACE, death in people with T2D